MP 17 (Thioridazine 50 mg)
Pill imprint MP 17 has been identified as Thioridazine hydrochloride 50 mg.
Thioridazine is used in the treatment of schizophrenia and belongs to the drug class phenothiazine antipsychotics. FDA has not classified the drug for risk during pregnancy. Thioridazine 50 mg is not subject to the Controlled Substances Act.
See also related documents.